About Anterios
Anterios is a company based in New York (United States) founded in 2006 by Robert Nicolosi and Jonathan T Edelson was acquired by Allergan in January 2016.. Anterios has raised $26.9 million across 7 funding rounds from investors including Allergan, Ascent Biomedical Ventures and DRW Trading Group. Anterios operates in a competitive market with competitors including GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others.
- Headquarter New York, United States
- Founders Robert Nicolosi, Jonathan T Edelson
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anterios Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Anterios
Anterios has successfully raised a total of $26.9M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $8.5 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $8.5M
-
First Round
First Round
(01 Jun 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2013 | Amount | Series A - Anterios | Valuation | Ascent Biomedical Ventures , DRW Trading Group |
|
| Jul, 2011 | Amount | Series A - Anterios | Valuation |
investors |
|
| Dec, 2010 | Amount | Series A - Anterios | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anterios
Anterios has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Allergan, Ascent Biomedical Ventures and DRW Trading Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on early-stage MedTech investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anterios
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anterios
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anterios Comparisons
Competitors of Anterios
Anterios operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anterios
Frequently Asked Questions about Anterios
When was Anterios founded?
Anterios was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Anterios located?
Anterios is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Anterios?
Jonathan T Edelson is the current CEO of Anterios. They have also founded this company.
Is Anterios a funded company?
Anterios is a funded company, having raised a total of $26.9M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Jun 01, 2007.
What does Anterios do?
Anterios was a clinical stage company developing novel delivery technologies and formulations for neurotoxins through skin. Anterios NDS proprietary platform delivery technology enables local, targeted delivery of neurotoxins through the skin without the need for injections. NDS also enables the formulation of macromolecules as ready-to-use liquid injectable products. Its lead drug ANT-1207 is a topical formulation of botulinum toxin type A for the potential treatment of hyperhidrosis (excessive sweating), acne, and crows feet lines. The company has completed a pair of Phase II studies in acne, crows feet lines and Hyperhidrosis, according to ClinicalTrials.gov. The company was acquired by Allergan in Jan 2016, before which it spun out its other assets, including an injectable botulinum, into a new firm called Eirion Therapeutics.
Who are the top competitors of Anterios?
Anterios's top competitors include Revance Therapeutics, Sutro Biopharma and Synthego.
Who are Anterios's investors?
Anterios has 7 investors. Key investors include Allergan, Ascent Biomedical Ventures, DRW Trading Group, Praesideo Management, and Quantum Technology Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.